Skip to content

BOSS: "Bioequivalence of oral protein supplements after bolus intake in healthy elderly"

BOSS: "Bioequivalence of oral protein supplements after bolus intake in healthy elderly"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24443
Enrollment
15
Registered
2015-12-22
Start date
2016-01-04
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bioequivalence

Interventions

After an overnight fast, subjects will ingest one dosage of one of the two study products at each study visit (except during screening).

Sponsors

Nutricia Research B.V., Utrecht, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Healthy volunteers - Age 60-80 years of age (both inclusive) - BMI from 20 through 30 kg/m2

Exclusion criteria

Exclusion criteria: - Any gastrointestinal (GI) disease or surgery that interferes with GI function - Known renal or hepatic failure - Known or suspected Diabetes Mellitus (fasting glucose level ¡Ý 7.0 mmol/L) - Fever (>38.5 oC) in the last 7 days prior to Visit 1

Design outcomes

Primary

MeasureTime frame
The primary outcome parameters in this study are amino acid AUC [ìmol/L*min] and Cmax [ìmol/L]

Secondary

MeasureTime frame
- Amino acid Tmax [min] and t½ AUC [min] - Glutamine, Essential amino acids and sum amino acids AUC [ìmol/L*min], Cmax [ìmol/L], Tmax [min] and t½ AUC [min] - Safety and GI tolerance parameters

Contacts

Public ContactA. van Helvoort

Nutricia Research

Email: A.vanHelvoort@nutricia.comTel. +31-30-2095000

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)